Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dexmedetomidine for bleeding reduction during functional endoscopic sinus surgery
IRCT20100126003186N12Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in chronic rhinosinusitis (CRS) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Quality of the surgical field and Amount of intraoperative bleeding. Started Sep 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on IRCT20100126003186N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100126003186N12.